Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Capital/Financing Update 2024

Nov 6, 2024

66262_rns_2024-11-06_721f8e12-ec7b-44de-8384-39c9c61c3472.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [101 x 28] intentionally omitted <==

QUOTATION NOTICE: NZX MAIN BOARD RUA BIOSCIENCE LIMITED (“RUARA”)

Issuer: Ticker Code: RUARA ISIN: NZRUAE0005S8 Details of Issue:

Rua Bioscience Limited (“RUA”)

A pro-rata renounceable rights issue of 3 new shares for every 4 existing shares held on the Record Date.

Ratio (New : Existing): 3 : 4 Exercise Price: NZ $0.025 per new share Issue Price Payable: In full on application Registrar: Computershare Investor Services Limited (“RMLT”) Settlement Status: NZCDC Settlement System

Key Dates Ex Rights Date: Tuesday, 12 November 2024 Rights Commence Trading: Tuesday, 12 November 2024 Record Date: 5pm, Wednesday, 13 November 2024 Letters of Entitlement sent to Thursday, 14 November 2024

Letters of Entitlement sent to Shareholders:

Retail Offer Opens: Thursday, 14 November 2024 Rights Quotation Ceases: Wednesday, 20 November 2024 Retail Offer Closes: Tuesday, 26 November 2024

Allotment and commencement of trading of New Shares (retail offer):

Monday, 2 December 2024

==> picture [137 x 65] intentionally omitted <==

Mark Peterson Chief Executive Officer NZX Limited

06 11 2024